News Summary

Anne Wojcicki, the founder of 23andMe, has successfully reacquired her genetic testing company in a second auction, following its bankruptcy. The auction saw Wojcicki’s TTAM Research Institute place a winning bid of $305 million, surpassing Regeneron Pharmaceuticals’ previous $256 million offer. This bid marks a significant increase from Wojcicki’s earlier bid of $146 million and an initial $40 million offer before the company’s bankruptcy filing. Wojcicki, who resigned as CEO in March, has been contesting the initial auction’s outcome and has now regained control of the company.